Retour
Omnimmune Holdings Inc (OMMH) Gagner
Graphique du cours de l'action OMMH
OMMH Gagner
Omnimmune Holdings Inc
$0
0%
$0
À la fermeture : Mar 23, 16:00:00 GMT-4
$0
0%
$0
Post-Marché: Mar 23, 20:00:00 GMT-4
Statistiques clés
Clôture préc.
$0.0001
Prix d'ouverture
$0
Plage de la journée
$0 - $0.0001
Plage de 52 semaines
$0.0001 - $0.0001
Volume
169.0K
Volume moyen
0
Rendement en dividend
--
BPA (TTM)
-0.20
Capitalisation boursière
$936
Qu’est-ce que OMMH ?
Omnimmune Holdings, Inc. is engaged in the provision of cancer therapeutic, diagnostic and prognostic technologies. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2007-12-19. The firm is the holding company of Omnimmune Corp. Omnimmune has acquired licensed rights to diagnostic and platform monoclonal antibody technologies. Omnimmune’s hCGß and related technologies, which are protected through an expanding intellectual property portfolio, have been developed at institutions including Columbia University of New York, New York (Columbia), The Allegheny-Singer Research Institute of the West Penn Allegheny Health System, Pittsburgh, Pennsylvania (Allegheny) and The Institute Gustave Roussy, Paris, France (IGR).
Fonctionnalités
Ressources
© 2026 Finture Development Limited. Tous droits réservés.
